WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance

BMJ. 2011 May 4:342:d2793. doi: 10.1136/bmj.d2793.
No abstract available

Publication types

  • News

MeSH terms

  • Antimalarials / therapeutic use*
  • Artemisinins / therapeutic use*
  • Drug Resistance*
  • Humans
  • Malaria / drug therapy*
  • Malaria / prevention & control
  • World Health Organization

Substances

  • Antimalarials
  • Artemisinins
  • artemisinin